Thank you for submitting your manuscript for consideration by The EMBO Journal. Three referees have now evaluated it, and their comments are shown below. As you will see, while referee 1 is a bit more critical, all three referees support publication of the manuscript here after appropriate revision. I would thus like to invite you to submit a revised version of the manuscript, addressing the comments of all three reviewers. In the light of the two more positive reports, I have consulted with referee 1 once more. While it would still be important to address his/her key points by some additional experimentation, he/she would not insist on addressing point 1b by further experiments. Please do not hesitate to contact me at any time in case you would like to consult on any aspect of the revision further.
I should add that it is EMBO Journal policy to allow only a single round of revision. Acceptance of your manuscript will therefore depend on the completeness of your responses in this revised version.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Peer Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html
We generally allow three months as standard revision time. As a matter of policy, competing manuscripts published during this period will not negatively impact on our assessment of the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely, Editor
The EMBO Journal
------------------------------------------------REFEREE COMMENTS Referee #1
Summary: This paper by Wang et al. deals with a topic of high interest, ciliary trafficking of rhodopsin regulated by Rab and Arf GTPases. This work continues on from the authors previously work (Mazelova et al., 2009 EMBO) describing rhodopsin TGN to rhodopsin transport carrier (RTC) trafficking regulation by Arf4, the Arf4 GAP ASAP1, and Rab11-FIP3 in frog photoreceptors. In this new work, the authors have further investigated the molecular mechanism of rhodopsin TGN-RTC trafficking and have extended their studies to mouse kidney cell (IMCD3) primary cilium. They show convincingly that ASAP1 is required for Rh-GFP-PxVx ciliary transport in these cells. The authors have also developed a powerful PLA assay to precisely localize interactions between Arf4, ASAP1, Rabs and rhodopsin in frog photoreceptor cells. The most important finding of this work was the discovery of a novel interaction between the ASAP1 BAR-domain and the rhodopsin FR motif, a motif conserved in ciliary GPCRs and previously shown to function in Smo ciliary trafficking. The authors suggest this interaction is required for Rho transport across the ciliary diffusion barrier, a poorly understood area at the base of the cilia thought to regulate trafficking into the cilia. Finally, the authors link ASAP1 and the Rab11-Rab8 cascade to rhodopsin TGN to RTC transport. Based on their biochemical and subcellullar localization studies the authors propose a plausible model for how these proteins coordinate rhodopsin TGN-cilia transport.
This work provides new mechanistic insights into rhodopsin ciliary transport pathways in photoreceptors that are important in the larger context for our understanding of primary cilium membrane trafficking and the growing list of cilia related diseases. The authors also developed novel biochemical approaches to study trafficking protein interactions in vivo in photoreceptors. The concern with this work is the potential problems drawing direct mechanistic comparison between IMCD3 cells and photoreceptor ciliary transport processes. It is important to highlight the differences of these systems in the text. Further suggestions in this regard and experiments that could help establish the conservation of the Arf4-ASAP1-Rab11-Rab8 TGN-cilia transport pathways in these systems are listed below.
Major comments: 1. a) From your model it would be predicted that ASAP1 depletion should block rhodopsin exit from the TGN in IMCD3 cells. To test this the authors should compare the periciliary localization of rhodopsin with markers of the golgi, TGN and other pericentriolar vesicular membrane markers. Also the significance of the actin detected near Rh-GFP-PxVX following ASAP1 depletion should be discussed in more detail or otherwise the data could be moved to supplemental. b) Is the altered localization of rhodopsin unique or might you see something similar with another ciliary receptor containing the PxVx motif? Because rhodopsin is not normally expressed in IMCD3 cells and at least in photoreceptors it is not necessary to add the PxVx motif following the GFP (in rhodopsin-GFP) characterization of another ciliary receptor (Sstr3, Smo, Ht6) with this motif following ASAP1 depletion would help establish the importance of ASAP1 in primary cilium receptor transport outside of the photoreceptor.
2. To further substantiate the biochemical finding that ASAP1 binds to rhodopsin peptides with an intact FR motif it would be important to demonstrate interactions in the full length protein (Rh-GFPPxVx and the FR-AA mutant CO-IP, PLA or colocalization studies). b) Without more direct evidence (binding or colocalization) of defective Rab8 association with rhodopsin FR-AA the statement on page 15 paragraph 2 last sentence is speculative at best. Another suggestion would be to directly test the dependence on Rab8 for ciliary transport of rhodopsin (RNAi or dominant negative expression). c) Lastly, based on the proposed model the FR-AA mutant protein should be retained in a post Golgi compartment. As suggest for the ASAP1 depletion studies comparisons to golgi, TGN, and Rab11 compartments should be done.
5. I feel the paper could have been better written in parts. I am also not accustomed to finding results descriptions in the supplemental data. 5. Figure 5C . In methods the source of myc-Rabin8 is not stated.
Referee #2
The manuscript of Wang et al seeks to evaluate the role of the Arf-GAP ASAP1 in regulating trafficking into renal cell primary cilia through interactions with Rab11a, Rab8a and Rabin8. This is a very detailed and beautifully illustrated paper that goes a long way to putting a great deal of hierarchical information into good context in renal cell trafficking to the primary cilium using a rhodopsin fragment as an assay. The careful presentation is extremely convincing and so my comments are relatively minor and mostly editorial:
Minor: 1) Figure 1I is confusing. The figure legend should describe that four amounts of control sample were loaded to provide comparison with the knockdown. At least I think that is what was done.
2) P10: Are the dots really 500 microns in size?
3) The authors use the term retinal PNS. I find this a bit confusing because "retinal" has other connotations other than "of the retina". I would suggest just using "retina PNS" or "PNS from the retina".
Referee #3
In this study Wang et al have further defined the role of the Arf GAP ASP1 in coordinating the transport of rhodopsin into the rod outer segment (ROS), a specialized cilia. Here they show that ASAP1 sequentially interacts with the cargo and Arf4 and then with Rab11a, Rabin8 and then Rab8 to coordinate and facilitate the polarized transport of rhodopsin into the primary cilia. A combination of elegant fluorescent localization techniques (including promity ligation analysis, PLA) and biochemical interaction studies are utilized in the study. The main finding of the study is that ASAP1 serves a scaffolding function and the importance of the FR targeting motif in rhodopsin that is recognized by ASAP that is critical for delivery of the protein into the ciliary membrane. It is perhaps a bit disappointing that other GPCRs that carry this FR motif do not use it to enter into cilia. On the other hand, the examination of rhodopsin transport in both retinal cells and in kidney inner medullary collecting duct cells reported here has significant physiological relevance.
The study is well documented and convincing. I would only make one suggestion. The authors might consider making some of the color figures with black & white for the single channel images (as opposed to color) with a color merge. In particular in Fig. 4N -P the blue images of Rab8 are difficult to discern; the distinct separation of the FR-AA mutant, Rab8 and the acetylated tubulin is hard to appreciate. We thank the reviewers for their helpful comments and suggestions for the improvement of our manuscript. We respond to the criticisms and suggestions in bold text below:
Referee #1 We appreciate the reviewer's constructive comments and understand the concern regarding the comparison between photoreceptors and IMCD3 cells in ciliary transport processes. We have embarked on these studies after gaining enough evidence that the ciliary transport is mechanistically conserved between the two cell types, fully justifying the combined use of photoreceptors and IMCD3 cells as model systems to study ciliary receptor trafficking. We have previously noted, but did not put enough emphases on their differences. We now devote the entire paragraph beginning on p. 21 and ending on 22 to the discussion of these differences, as suggested by the reviewer.
Further suggestions in this regard and experiments that could help establish the conservation of the Arf4-ASAP1-Rab11-Rab8 TGN-cilia transport pathways in these systems are listed below.
Major comments:
a) From your model it would be predicted that ASAP1 depletion should block rhodopsin exit from the TGN in IMCD3 cells. To test this the authors should compare the periciliary localization of rhodopsin with markers of the golgi, TGN and other pericentriolar vesicular membrane markers. Also the significance of the actin detected near Rh-GFP-PxVX following ASAP1 depletion should be discussed in more detail or otherwise the data could be moved to supplemental.
Our study indicates that ASAP1 depletion does not block rhodopsin exit from the TGN in IMCD3 cells, but causes its mistargeting to a novel structure that does not exist in cells expressing ASAP1. This is likely due to the existence of another Arf GAP at the TGN that may partially fulfill the GAP function of ASAP1, but does not fulfill its effector function. ASAP1 is a known regulator of membrane trafficking and actin cytoskeleton rearrangements and we now discuss the significance of the periciliary actin detected in ASAP1 depleted cells, as requested by the reviewer. We now explain on p 21 that ASAP1 may coordinate membrane traffic and cytoskeletal changes at the ciliary base thereby clearing the way for ciliary membrane carriers, which could explain why its absence causes mistargeting of a ciliary receptor. Because IMCD3 cells are not dedicated to ciliary transport to the same extent as photoreceptor cells we did not comprehensively analyze the dynamic intracellular compartments in these cells that are not fully polarized when we evaluate them. We now explain on p. 18 and on p. 22 how do photoreceptors and IMCD3 cells relate to each other.
b) Is the altered localization of rhodopsin unique or might you see something similar with another ciliary receptor containing the PxVx motif? Because rhodopsin is not normally expressed in IMCD3 cells and at least in photoreceptors it is not necessary to add the PxVx motif following the GFP (in rhodopsin-GFP) characterization of another ciliary receptor (Sstr3, Smo, Ht6) with this motif following ASAP1 depletion would help establish the importance of ASAP1 in primary cilium receptor transport outside of the photoreceptor.
We agree with the reviewer that it would be important to compare other ciliary receptors to rhodopsin. However, these experiments are outside of the scope of the present study, because the characterization of even one additional ciliary receptor would require extensive additional experimentation and data analysis, which is not compatible with the time frame for the revision of this manuscript.
To further substantiate the biochemical finding that ASAP1 binds to rhodopsin peptides with an intact FR motif it would be important to demonstrate interactions in the full length protein (Rh-GFP-PxVx and the FR-AA mutant CO-IP, PLA or colocalization studies).
We thank the reviewer for this suggestion. We have performed the PLA analysis in IMCD3 cells and found that ASAP1 binds Rh-GFP-VxPx, but does not interact with the FR-AA mutant. This is shown in Fig 4K and L and described on p. 15, first paragraph.
As indicated in the manuscript ASAP1 is required for ciliogenesis. In the discussion page 19 paragraph 1 line 5 it states "we found that the loss of ASAP1 does not initially affect ciliogenesis per se". It is not clear what that means. Is ASAP1 required for IMCD3 ciliogenesis?
Our study shows that ASAP1 is not required for ciliogenesis, because cilia appear normal after short-term depletion of ASAP1 (p. 8, second paragraph). ASAP1 is required for the ciliary access of specific components and receptors, such as rhodopsin. We now clarify this on p 21, first paragraph. The new Fig 5G shows the complete absence of colocalization of [FR-AA]Rh-GFP-VxPx and Rab8. The analysis is described on p. 15 and 16. RNAi of Rab8 has been performed in previous studies and resulted in the absence of cilia, which has led to the conclusion that Rab8 is essential for ciliogenesis (Nachury et al, 2007 , Yoshimura et al, 2007 . Unfortunately, for that reason RNAi of Rab8 cannot be used to study ciliary targeting.
a) Does Rh-GFP-PxVx colocalize with Rab8 in IMCD3 cells outside of the cilia? This is important to determine since the images showing different localizations of the FR-AA mutant with

c) Lastly, based on the proposed model the FR-AA mutant protein should be retained in a post Golgi compartment. As suggest for the ASAP1 depletion studies comparisons to golgi, TGN, and Rab11 compartments should be done.
We now clearly state on p. 22 that there are distinct differences in the topography of the photoreceptor cells and the IMCD3 cells used as a model in our studies, therefore the post-Golgi compartment of IMCD3 cells can not be easily defined and compared to the terminally differentiated photoreceptors, which are dedicated to active ciliary transport. ASAP1 depletion does not block rhodopsin exit from the TGN in IMCD3 cells. Figure 4G and I and the new Figure 5C , D and G show that the [FR-AA] mutant defective in ASAP1 binding accumulates near the ciliary exclusion zone, but does not contact the Rab8-postive periciliary compartment. Interestingly, in cells expressing Rh-GFP-VxPx this compartment is less prominent, suggesting that it may be more dispersed when it is engaged in the "quality control" of the ciliary cargo.
I feel the paper could have been better written in parts. I am also not accustomed to finding results descriptions in the supplemental data.
We appreciate the reviewers comment and have made every effort to present a revised paper that is more clear and readable. Because of the space limitations, it is not uncommon to find results that form the foundation to the complex studies in the supplemental data. Figure 5I legend detail could be removed and discussed in the discussion.
We presume that the reviewer refers to the Figure 5O legend. This has been removed and discussed on p. 19 and p. 22. Figure 5O is now Figure 6O and it has been modified accordingly. The experiments described on p. 13, paragraph 3, line 1 were done using purified bovine rhodopsin, as stated. However, within the same paragraph we began the description of GST-fusion proteins. We revised this part (p. 13, second paragraph) to state: "We compared the binding of ASAP1 to a GST-fusion protein containing the peptide corresponding to rhodopsin H-8 (AA 310-321) WT, or the rhodopsin H-8 FR-AA mutant."
3. Page 13 paragraph 3 line should be RhCt) to be consistent with Figure 3D labels
This has been changed, as requested.
Page 14 paragraph 2 -description of Rh-GFP-PxVx has already been given from Figure 1, repetitive.
This has been removed, as requested.
5. Figure 5C . In methods the source of myc-Rabin8 is not stated.
This has been stated on p. 24, paragraph 1, as requested.
Referee #2 We thank the reviewer for the supportive evaluation and for pointing out this omission. The Figure  legend to Fig 1 has been revised, as suggested.
2) P10: Are the dots really 500 microns in size?
We thank the reviewer for pointing out this mistake. The dots are 500 nm or 0.5 µm in size. This has been corrected on p. 10, paragraph 2.
We thank the reviewer for this observation and have replaced this term on p 9, 16 and elsewhere to avoid the confusion. We thank the reviewer for the positive comments. We agree with the observation that it is very difficult to see the blue images, particularly in the printed version. We have split Figure 4 into two figures, so the former Fig 4N- P is now Fig 5B-E . We have replaced the color panels with black and white panels in Fig 5D and E. Thank you for sending us your revised manuscript. Referee 1 has now seen it again, and you will be pleased to learn that in his/her view you have addressed all criticisms in a satisfactory manner. He/she has just one minor comment that you may wish to take into account (please see below).
Prior to formal acceptance, there are a number of editorial issues that need further attention:
* According to our guidelines, the manuscript should not contain a supplementary results section. I would therefore like to ask you to include this text section into the main body of the manuscript. It is fine to keep the supplementary figures themselves in the supplementary material. We are ready to compromise with respect to the manuscript length to accommodate for this additional text.
* Please add an author contribution section and a conflict of interest statement to the main body of the manuscript text after the acknowledgements section.
* Could you check all scale bars and their explanations in the figure legends (including those in the supplementary material) once again, please, to make sure that all of the micrographs have visible scale bars together with explanations.
Thank you very much again for considering our journal for publication of your work. We are looking forward to receiving the final version of the manuscript.
Yours sincerely,
Editor
